Clinical trial
Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus
NCT05860413 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus
- Lead sponsor
- University of Kansas Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 24, 2023
- Completion date
- May 20, 2025
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes